Literature DB >> 17786317

Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.

Damilola Akinmade1, Myounghee Lee, Yuexing Zhang, Anne W Hamburger.   

Abstract

Ebp1 is an ErbB3 binding phosphoprotein with pleiotropic effects. Overexpression of Ebp1 represses transcription of E2F1 responsive cell cycle regulated genes and inhibits cell growth. However, the effect of phosphorylation on Ebp1-mediated transcriptional repression and cell growth inhibition is currently unknown. In this study, we show that serine 363 (S363) of Ebp1 is phosphorylated in vivo. Although total Ebp1 is located in the nucleus, organelles and the cytoplasm, Ebp1 phosphorylated at S363 (Ebp1 pS363) is localized exclusively to the nucleus. Mutation of S363 to alanine did not change the subcellular localization of Ebp1. However, the S363A mutation significantly decreased the ability of Ebp1 to repress transcription and abrogated its ability to inhibit cell growth. We have previously shown that Ebp1 can bind the E2F1 promoter in vitro and in vivo as part of a protein complex and that Ebp1-transcriptional repression is mediated via its interaction with the co-repressors HDAC2 and mSin3a present in this complex. Although Ebp1 S363A interacted with an E2F1 promoter element, it did not bind HDAC2 and mSin3a. These results indicate the importance of S363 phosphorylation in the function of Ebp1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786317

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

Review 1.  The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.

Authors:  Anne W Hamburger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-19       Impact factor: 2.673

2.  The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.

Authors:  Yan Lu; Hua Zhou; Wantao Chen; Yuexing Zhang; Anne W Hamburger
Journal:  Breast Cancer Res Treat       Date:  2010-04-09       Impact factor: 4.872

3.  Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer.

Authors:  Hua Zhou; Krystyna Mazan-Mamczarz; Jennifer L Martindale; Andrew Barker; Zhenqiu Liu; Myriam Gorospe; Peter J Leedman; Ronald B Gartenhaus; Anne W Hamburger; Yuexing Zhang
Journal:  Nucleic Acids Res       Date:  2010-02-16       Impact factor: 16.971

4.  Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.

Authors:  Hui-chan He; Xiao-hui Ling; Jian-guo Zhu; Xin Fu; Zhao-dong Han; Yu-xian Liang; Ye-han Deng; Zhuo-yuan Lin; Guo Chen; Yan-fei Chen; Ru-jun Mo; Wei-de Zhong
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

Review 5.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

6.  Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor.

Authors:  Zhixue Liu; Sang-Muk Oh; Masashi Okada; Xia Liu; Dongmei Cheng; Junmin Peng; Daniel J Brat; Shi-yong Sun; Wei Zhou; Wei Gu; Keqiang Ye
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

7.  Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice.

Authors:  Yuexing Zhang; Yan Lu; Hua Zhou; Myounghee Lee; Zhenqiu Liu; Bret A Hassel; Anne W Hamburger
Journal:  BMC Cell Biol       Date:  2008-12-18       Impact factor: 4.241

8.  ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.

Authors:  Arundhati Ghosh; Smita Awasthi; Anne W Hamburger
Journal:  Oncol Rep       Date:  2012-12-14       Impact factor: 3.906

9.  Expression of ErbB3-binding protein-1 (EBP1) during primordial follicle formation: role of estradiol-17ß.

Authors:  Anindit Mukherjee; Shyamal K Roy
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.

Authors:  D Akinmade; A H Talukder; Y Zhang; W-M Luo; R Kumar; A W Hamburger
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.